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INTRODUCTION 
Low serum Vitamin B12 levels become more common with aging. 
It has been recently found that approximately 10% to 15% of older adults 
have Vitamin B12 deficiency. The older the patient and the more profound 
the signs and symptoms, the less likely the recovery. 
Vitamin B12 deficiency can present clinically as a hematologic 
disorder that causes macrocytosis and anemia or a neurological disorder 
that can cause a peripheral neuropathy and spinal cord lesions or with 
neuropsychiatric manifestations, including delirium, depression, 
confusion, memory loss and poor language, comprehension and 
expression. Since patients with more severe hematologic signs often have 
less neurologic impairment and vice versa, it is important to consider 
vitamin B12 deficiency even if the patient lacks macrocytosis and anemia. 
Thus, although serum Vitamin B12 levels become low with aging it 
often goes unnoticed. Hence screening of all older adults for vitamin B12 
should be considered and supplementation of all deficient patients is 
recommended. 
 
REVIEW OF LITERATURE 
Vitamin B12, also called cobalamin, is a water-soluble 
vitamin with a key role in the normal functioning of 
the brain and nervous system, and for the formation of blood. It is 
normally involved in the metabolism of every cell of the human body, 
especially affecting DNA synthesis and regulation, but also fatty 
acid synthesis and energy production. It is the largest and most 
structurally complicated vitamin and can be produced industrially only 
through bacterial fermentation-synthesis. 
Cobalamin (vitamin B12) exists in a number of different chemical 
forms. All have a cobalt atom at the center of a corrin ring. In nature, the 
vitamin is mainly in the 2-deoxyadenosyl  form, which is located in 
mitochondria. It is the cofactor for the enzyme methylmalonyl CoA 
mutase. The other major natural cobalamin is methylcobalamin, the form 
in human plasma and in cell cytoplasm. It is the cofactor for methionine 
synthase. 
Dietary Sources and Requirements 
Cobalamin is synthesized solely by microorganisms. Ruminants 
obtain cobalamin from the foregut, but the only source for humans is food 
of animal origin, e.g., meat, fish, and dairy products. Vegetables, fruits, 
and other foods of non-animal origin are free from cobalamin unless they 
are contaminated by bacteria. Herrmann. W and Geisel. J in 2002 
studied the influence of vegetarian lifestyle on vitamin B12 status in the 
body(1). Adult daily losses (mainly in the urine and feces) are between 1 
and 3 g (~0.1% of body stores) and, as the body does not have the ability 
to degrade cobalamin, daily requirements are also about 1–3 g. Body 
stores are of the order of 2–3 mg. 
Rajan S and Wallace JI et al in 2002 described the prevalence of 
cobalamin (Cbl) deficiency in older adult outpatients and to determine 
whether regular intake of a synthetic source of cobalamin confers 
protection against Cbl deficiency(2). 
Absorption 
Two mechanisms exist for cobalamin absorption. One is passive, 
occurring equally through buccal, duodenal, and ileal mucosa; it is rapid 
but extremely inefficient, <1% of an oral dose being absorbed by this 
process. The normal physiologic mechanism is active; it occurs through 
the ileum and is efficient for small (a few micrograms) oral doses of 
cobalamin and is mediated by gastric intrinsic factor (IF). Dietary 
cobalamin is released from protein complexes by enzymes in the 
stomach, duodenum, and jejunum; it combines rapidly with a salivary 
glycoprotein that belongs to the family of cobalamin-binding proteins 
known as haptocorrins (HCs). In the intestine, the haptocorrin is digested 
by pancreatic trypsin and the cobalamin transferred to IF. IF is produced 
in the gastric parietal cells of the fundus and body of the stomach. The IF-
cobalamin complex passes to the ileum, where IF attaches to a specific 
receptor (cubilin) on the microvillus membrane of the enterocytes. The 
cobalamin-IF complex enters the ileal cell where IF is destroyed. After a 
delay of about 6 hours, the cobalamin appears in portal blood attached to 
transcobalamin (TC) II.  Between 0.5 and 5.0 g of cobalamin enters the 
bile each day. This binds to IF, and a major portion of biliary cobalamin 
is normally reabsorbed together with cobalamin derived from sloughed 
intestinal cells. Because of the appreciable amount of cobalamin 
undergoing enterohepatic circulation, cobalamin deficiency develops 
more rapidly in individuals who malabsorb cobalamin than it does in 
vegans, in whom reabsorption of biliary cobalamin is intact.  Swain R in 
1995 reviewed information on cyanocobalamin (Vitamin B12) deficiency, 
changing options in laboratory testing for deficiency states, and options 
for treatment(9). High-risk groups for the deficiency syndrome included 
the elderly, patients taking ulcer medications over long periods, patients 
with AIDS, vegetarians, patients who had undergone stomach resection 
or small bowel resection, and patients with dementia.                 
Transport 
Two main cobalamin transport proteins exist in human plasma; 
they both bind cobalamin—one molecule for one molecule. One 
Haptocorrin, known as Transcobalamin I, is closely related to other 
cobalamin-binding HCs in milk, gastric juice, bile, saliva, and other 
fluids. These HCs differ from each other only in the carbohydrate moiety 
of the molecule. TC I is derived primarily from the specific granules in 
neutrophils. Normally, it is about two-thirds saturated with cobalamin, 
which binds it tightly. TC I does not enhance cobalamin entry into 
tissues. Glycoprotein receptors on liver cells are involved in the removal 
of TC I from plasma, and TC I may have a role in the transport of 
cobalamin analogues to the liver for excretion in bile.  The other major 
cobalamin transport protein in plasma is TC II. This is synthesized by 
liver and by other tissues, including macrophages, ileum, and 
endothelium. It normally carries only 20–60 ng of cobalamin per liter of 
plasma and readily gives up cobalamin to marrow, placenta, and other 
tissues, which it enters by receptor-mediated endocytosis. 
Vitamin B12 belongs to the family of cobalamins and serves as a 
cofactor for two important reactions in humans. As methylcobalamin, it is 
a cofactor for methionine synthetase in the conversion of homocysteine to 
methionine, and as adenosylcobalamin for the conversion of 
methylmalonyl-coenzyme A (CoA) to succinyl-CoA.  
Aetiology(4) 
The causes of vitamin B12deficiency in elderly are as follows; 
 Atrophic gastritis and hypochlorhydria ( Andrews GR et al 
1967)(5) 
 Chronic antacid use (H-2 blockers, PPIs) { Howden CW-
2000}(6)  
 Gastric surgery ( Sumner AE et al 1996 )(7) 
 Ileal surgery 
 Diseases of the small intestine and terminal ileum: Crohn‘s 
disease, sprue, malabsorption syndromes 
 Helicobacter pylori infection 
 Pancreatic insufficiency 
 Parasitic infections of small bowel (eg; fish tapeworm) 
 Bacterial overgrowth syndromes 
 Strict vegetarianism 
 Acquired Immunodeficiency Syndrome (AIDS) and AIDS 
treatment ( e.g: zidovudine ) 
 Pernicious anemia 
 Possibly metformin 
Pathogenesis of Cobalamin Deficiency 
Nutritional Cobalamin Deficiency 
Vegetarianism is an important cause of nutritional cobalamin 
deficiency in developing countries. 
Inadequate Dissociation of Cobalamin from Food Protein 
Dietary cobalamin requires proteolytic digestion of food by gastric 
acid and pepsin and failure to release cobalamin from food protein can 
lead to cobalamin deficiency despite the presence of intrinsic factor. 
Absent Secretion 
Deficiency of intrinsic factor as a result of gastric parietal cell 
atrophy is associated with insufficient HCl secretion and can be caused 
by (1) total or partial gastrectomy, (2) autoimmune destruction (chronic 
atrophic gastritis) as found as in classic pernicious anemia, or (3) 
destruction of gastric mucosa by caustic (lye) ingestion. 
Total gastrectomy invariably leads to cobalamin deficiency in 2 to 
10 years, thus warranting prophylactic cobalamin (and iron) replacement. 
After partial gastrectomy, up to a third of patients may have multifactorial 
cobalamin deficiency from decreased secretion of intrinsic factor, 
hypochlorhydria, or intestinal bacterial overgrowth of cobalamin-
consuming organisms. Morbidly obese patients who have undergone 
gastric bypass surgery have more malabsorption of cobalamin from food 
than do those treated by vertical banded gastroplasty. Malabsorption of 
cobalamin can also occur with the long-term use of H2 blockers or proton 
pump inhibitors. 
In pernicious anemia, the primary event is autoimmune destruction 
and atrophy of the gastric parietal cell mucosa, thereby leading to the 
absence of intrinsic factor and HCl, which causes severe cobalamin 
malabsorption and deficiency. The autoimmune gastritis that eventually 
leads to chronic atrophic gastritis involves the gastric fundus and body. 
Intrinsic factor antibodies are found in the serum of 60% and in the 
gastric juice of 75% of patients with pernicious anemia. Type I anti–
intrinsic factor antibodies prevent binding of cobalamin to intrinsic factor, 
whereas type II anti–intrinsic factor antibodies prevent binding of 
intrinsic factor–cobalamin complexes to ileal intrinsic factor–cobalamin 
receptors and can interfere with tests for cobalamin absorption.  
Abnormal Events Precluding Absorption of Cobalamin 
Pancreatic insufficiency with a deficiency of pancreatic protease 
will fail to break down the R proteins to which cobalamin is preferentially 
bound in the stomach, thereby precluding transfer of cobalamin to 
intrinsic factor. However, with the widespread early use of pancreatic 
replacement, frank cobalamin deficiency is now uncommon. Endogenous 
pancreatic protease can be inactivated by massive gastric hypersecretion 
arising from a gastrinoma in Zollinger-Ellison syndrome, where the low 
pH of the luminal contents in the ileum can also preclude binding of the 
intrinsic factor–cobalamin complex with intrinsic factor–cobalamin 
receptors, a process that requires a pH higher than 5.4. 
Bacterial overgrowth in the small bowel  (arising from stasis, 
impaired motility, and hypogammaglobulinemia) favors colonization by 
bacteria, which can then usurp free cobalamin before it can bind to 
intrinsic factor; this problem can be reversed by a short course of 
antibiotic therapy. Individuals heavily infested with the fish tapeworm 
Diphyllobothrium latum  can become cobalamin deficient when these 10-
m-long adult worms in the jejunum avidly usurp cobalamin. After the 
worms have been expelled (praziquantel, 10 to 20 mg/kg, single dose 
orally), cobalamin replenishment is curative. 
Disorders of the Intrinsic Factor Receptors or Mucosa 
Because the distal ileum has the greatest density of intrinsic factor–
cobalamin receptors, removal, bypass, or dysfunction of only 1 to 2 ft of 
terminal ileum can result in cobalamin malabsorption. Among drugs, 
biguanides (i.e., metformin) decrease intrinsic factor and acid secretion 
and can inhibit transenterocytic transport of cobalamin in up to a third of 
patients, which can be avoided by intake of calcium (1.2 g/day). Other 
drugs (extended-release potassium chloride, cholestyramine, colchicine, 
and neomycin) can also impair transepithelial transport of cobalamin and 
interfere with the Schilling test. 
Acquired Cobalamin Deficiency 
Nitrous oxide (N2O) irreversibly inactivates cobalamin and results 
in a state of functional intracellular cobalamin deficiency, which can be 
bypassed by administration of 5-formyl-THF (leucovorin). Although 
N2O exposure during prolonged surgery can induce megaloblastosis, 
especially in those with marginal or low cobalamin stores, chronic 
intermittent (surreptitious, accidental, or occupational) exposure leads 
more frequently to a neuromyelopathic manifestation. 
Clinical presentations of vitamin B12 deficiency 
Physical examination of cobalamin-deficient vegetarians or those 
with pernicious anemia may reveal well-nourished individuals. By 
contrast, patients with folate deficiency are poorly nourished and may 
have other stigmata of multiple deficiencies from malabsorption. Varying 
degrees of pallor with lemon-tint icterus are common features of 
megaloblastosis. The skin may reveal either a diffuse brownish 
pigmentation or abnormal blotchy tanning. Premature graying is observed 
in both light- and dark-haired individuals. 
Examination of the mouth may reveal glossitis with a smooth 
(depapillated), beefy red tongue and occasional ulceration of the lateral 
surface. Thyromegaly may be observed in the neck if there is associated 
autoimmune disease. The characteristic findings of cardiovascular failure 
from severe anemia may be accompanied by mild splenomegaly and 
extramedullary hematopoiesis. 
Nutritional cobalamin deficiency in developing countries can be 
manifested as florid pancytopenia, mild hepatosplenomegaly, fever, and 
thrombocytopenia, with the neuropsychiatric syndrome developing as a 
later manifestation. However, cobalamin-related neurologic disease has 
also been found in patients with only mild to moderate anemia secondary 
to cobalamin deficiency in both developing and developed countries. 
Between 25 and 50% of patients who have neuropsychiatric 
abnormalities attributable to cobalamin deficiency can have a normal 
hematocrit and MCV if they have adequate folate stores to protect them 
from hematologic abnormalities. Dharmarajan TS et al in 2003 did a 
study to identify subtle symptoms in older adults due to vitamin B12 
deficiency and recognized that food - cobalamin  malabsorption is the 
most common cause of the deficiency.(8)  
Vitamin B12  Deficiency and Anemia 
Megaloblastosis 
To establish the diagnosis of megaloblastosis, the evaluation begins 
with a complete blood count, MCV (which often reveals a steady increase 
over a period of several months or years), peripheral smear, and 
reticulocyte count . Classic megaloblastosis from cobalamin deficiency 
may be accompanied by a hemoglobin level of less than 5 g/dL. 
Neutropenia and thrombocytopenia occur less commonly than anemia 
and are not usually severe. Occasionally, however, neutrophil counts less 
than 1000/μL and platelet counts less than 50,000/μL can be seen. 
Additional abnormalities supporting intramedullary hemolysis include 
elevated levels of serum lactate dehydrogenase and bilirubin, as well as 
decreased serum haptoglobin levels. 
Megaloblastic anemia can be masked when there is a coexisting 
condition that neutralizes the tendency to generate large cells, such as 
with iron deficiency or thalassemia and it can be identified by giant 
myelocytes and metamyelocytes in bone marrow and hypersegmented 
neutrophils in bone marrow and peripheral blood. This problem is 
clinically relevant because appropriate replacement with cobalamin  will 
elicit a maximal hematologic response only when any associated iron 
deficiency is corrected. Conversely, if combined iron and cobalamin 
deficiency (after gastrectomy)  is treated with iron alone, megaloblastosis 
will be unmasked. Thus, the diagnosis of megaloblastic anemia should 
not be excluded until bone marrow aspirates have been examined and the 
presence of bone marrow iron is established. 
Peripheral blood – oval macrocytes, usually with considerable 
anisocytosis and poikilocytosis are the main feature.the MCV is usually > 
100 fL. Some of the neutrophils are hypersegmented. There may be 
leucopenia due to reduction in granulocytes and lymphocytes and the 
platelet count may be moderately reduced. The severity of all these 
changes parallels the degree of anemia.(9) 
Bone marrow - The marrow is hypercellular in the severely 
anemic patient. The cells are larger than normoblasts, and an increased 
number of cells with eccentric lobulated nuclei or nuclear fragments may 
be present. Giant and abnormally shaped metamyelocytes and enlarged 
hyperpolypoid megakaryocytes are characteristic. 
Wendy P J den Elzen et al in 2010 did a systematic review about 
the association between subnormal vitamin B12 concentrations and anemia 
in older people(10).  
Van Asselt et al in 2000 did a study about the clinical significance 
of low cobalamin levels in older hospital patients(11). In this prospective 
observational cohort design, study involved 28 patients aged 65 years and 
older with low plasma Cbl (150 pmol/ l). A number of haematological , 
metabolic and gastrointestinal  parameters, and the response to Cbl 
treatment, were measured. Cbl deficiency was considered to be present 
when at least one of the following three criteria was fulfilled: (1) 
haematological or metabolic abnormalities compatible with Cbl 
deficiency; (2) Cbl malabsorption or atrophic gastritis; (3) a response to 
Cbl supplementation. 
Vitamin B12  deficiency and Neuropathy 
The existence of vitamin B12 deficiency neuropathy was recognized 
in 1958. The neurologic manifestation of cobalamin deficiency is less 
well understood but CNS demyelination may occur which may be due to 
reduced S-adenosyl methionine (SAM) or elevated methylmalonic acid 
(MMA). Another cause may involve adenosylcobalamin, a mitochondrial 
cofactor in the conversion of L-methylmalonyl CoA to succinyl CoA. 
Vitamin B12 deficiency leads to an increase in L-methylmalonyl CoA 
which is converted to D-methylmalonyl CoA and hydrolyzed to MMA. 
Elevated MMA results in abnormal myelination leading to defective 
nerve transmission. 
SUBACUTE COMBINED DEGENERATION OF THE CORD(12) 
It is also termed as Posterolateral sclerosis or Combined system 
disease. 
DEFINITION 
It is a deficiency disease, usually associated with pernicious 
anemia, and characterized pathologically by degeneration of the white 
matter of the spinal cord,which is most evident in the posterior and lateral 
columns, and of the peripheral nerves and brain, and clinically by 
paraesthesiae, impairment of position and joint sense, sensory ataxia, and 
paraparesis. This was reviewed by Healton EB and Lindenbaum J et al 
in 1991 and later studied by Savage DG and Lindenbaum J in 
1995(13,14).   The clinical picture is usually due to combined features of 
posterior-column, corticospinal-tract, and peripheral-nerve degeneration, 
but involvement of the optic nerves and brain is not uncommon. 
The onset of symptoms is usually gradual, but is sometimes rapid. 
The first symptoms are generally paraesthesiae, with tingling sensations, 
first felt in the tips of the toes, and later in the fingers. Other paraesthesias 
often described include sensations of numbness, coldness, and tightness, 
while sharp stabbing pains ocassionally occur. Objective sensory changes 
are almost present, involving first the forms of sensibility mediated by the 
posterior columns. Postural sensibility and appreciation of passive 
movement and of vibration are impaired first in the lower, and later in the 
upper limbs. Cutaneous sensibility to light touch, pin-pick, heat, and cold 
is impaired at first in the periphery, leading to the characteristic ‗glove  
and stocking‗ distribution of superficial sensory loss. The calves may be 
tender on pressure. The proximal border of the anaesthetic areas may then 
ascend gradually. 
In some cases weakness and spasticity predominate in the lower 
limbs while in others there may be predominance of sensory ataxia, but 
both weakness and sensory ataxia are usually present in the lower limbs, 
and are most severe in the lower with a positive Rhomberg‘s sign. 
Moderate muscular wasting may develop in the later stages due to the 
peripheral neuropathy, and it mainly involves the peripheral muscles. 
The reflexes vary considerably. In about 50 per cent of cases the 
ankle-jerks are absent when the patient is first seen; the knee-jerks are 
lost rather less frequently; in other cases both are exaggerated. The 
plantar reflexes are flexor at first in about half the cases, but later become 
extensor in all but a few. When the degeneration is confined to the 
posterior columns, ataxia is the predominant symptom throughout and 
signs of corticospinal defect are lacking. Conversely, spastic paraplegia 
may alone be present while in yet other cases signs of peripheral 
neuropathy predominate. 
Sphincter disturbances may occur in the form of urinary retention 
or incotinence. Impotence sometimes occurs early. 
Bilateral primary optic trophy with some visual impairment is 
observed in about 5 per cent of cases and may even be the presenting 
feature with central scotoma (Freeman and Heaton 1961); Nystagmus is 
common. The pupils may be small, but react normally. Otherwise the 
cranial nerves are usually normal, though dysarthria occurs rarely. 
Vitamin B12 Deficiency and Cognitive Impairment 
There are many possible mechanisms through which low-normal 
vitamin B12 status could influence the functioning of the brain, and hence 
cognition, and these mechanisms are not mutually exclusive. One 
possibility is that the effect is mediated by homocysteine, because low 
vitamin B12 status is associated with an elevation of the concentration of 
tHcy. Many mechanisms have been proposed for the effects of 
homocysteine on the brain, apart from an effect on the cerebral 
vasculature. Alternatively, the effect of low vitamin B12 status might be 
mediated by the raised concentrations of MMA, as discussed by 
McCracken et al; notably, the concentration of MMA in cerebrospinal 
fluid is twice that in plasma. Classical deficiency of vitamin B12 is 
accompanied by alterations in the concentrations of cytokines, such as 
tumor necrosis factor-α or epidermal growth factor. The commonest 
hypothesis, however, for the neurotoxic effects of low vitamin B12 status 
is that it leads to a deficiency of S-adenosylmethionine (SAM) and 
thereby to deficient methylation reactions in the central nervous system . 
On a more global level, low-normal vitamin B12 status might 
mediate the effect on cognition by two mechanisms, atrophy of the brain 
and damage to the white matter. Progressive loss of brain tissue (atrophy) 
is well established as a factor associated with cognitive decline and 
dementia  and recently it was shown that low-normal vitamin B12 status at 
baseline is a predictor of whole-brain atrophy in community-dwelling 
elderly. Progressive atrophy of the brain was associated with plasma 
vitamin B12 concentrations ranging from 800 to 160 pmol/L and with 
holotranscobalamin concentrations from 250 to 25 pmol/L. There was no 
obvious threshold concentration below which atrophy began. 
Classical vitamin B12 deficiency is associated with damage to the 
white matter in the spinal cord and in the brain, which has been attributed 
to damage to myelin as a result of deficient methylation of myelin basic 
protein. There is much evidence that damage to the white matter in the 
brain is associated with, and may precede, cognitive decline. It is 
therefore noteworthy that, in participants in the Rotterdam scan study, 
damage to the white matter was related to vitamin B12 status over the 
normal range, as assessed by plasma total vitamin B12, 
holotranscobalamin, transcobalamin saturation, and MMA. Previous case 
reports of patients with vitamin B12 deficiency reported that changes in 
the white matter are reversible with treatment with vitamin B12.  
Thus, it can be concluded that the cognitive deficit associated with 
low-normal vitamin B12 status may be due in part to loss of brain tissue 
over many years but also to potentially reversible damage to the white 
matter. However, to find out whether these associations are causal 
requires intervention studies. 
Addison in 1849 noticed that ―The mind occasionally wanders‖ in 
his patients which was cited by McCaddon(15). 
Barrett in 1913 described histopathological changes in the cerebral 
cortex, notably neurodegeneration and damage to the white matter and 
blood vessels(16). 
The idea that low-normal concentrations of vitamin B12 might be 
associated with cognitive impairment was raised by Bell et al in 1990 
(17) and clearly expressed by Rosenberg and Miller in their seminal 
review 2 years later(18). 
Bernard MA et al in 1998 examined the effect of vitamin B12 
deficiency on older veterans and its relationship to general health and 
cognitive impairment(19). 
Prevalence of vitamin B12 deficiency among demented patients and 
cognitive recovery with cobalamin replacement was studied by Abyad A 
in 2002(20)  and by Andres E and Kaltenbach G in 2003(21). 
Joshua W Miller in 2006 assessed the association between 
vitamin B12 status and cognitive function in older adults, but the findings 
were inconsistent(22). 
A. David Smith and Helga Refsum in 2009 reviewed that 
cognition in the elderly may also be affected at concentrations of vitamin 
B12 above the traditional cutoffs for deficiency(23). 
Laboratory diagnosis 
Serum cobalamin should be measured whenever there is suspicion 
of vitamin B12 deficiency. The method now used is a commercial 
radioisotope dilution assay (or chemiluminescence assay). The normal 
range used in our study is 211-946 pg/mL.With this method a serum B12 
level of less than 100 pg/mL is associated with neurological symptoms 
and signs of vitamin B12 deficiency. A level below 200 pg/mL  that is not 
associated with symptoms requires further investigation of cobalamin 
deficiency. High serum concrntrations of cobalamin metabolites- 
methylmalonic acid (normal range, 73 to 271 nmol/L) and homocysteine  
(normal range 5.4 to 16.2 mmol/L) are probably the most reliable 
indicators of an intracellular cobalamin deficiency and can be used to 
corroborate the diagnosis. 
About 90% of older patients with serum cobalamin levels less than 
200 pg/mL show evidence of true tissue cobalamin deficiency, but 
individuals with neuropsychiatric disorders attributed to cobalamin 
deficiency may not have anemia and may have normal or minimally 
depressed cobalamin levels. Indeed, mild and usually subclinical 
cobalamin deficiency has been recognized in up to a quarter of free-living 
elderly (75 to 80 years of age). A falsely raised cobalamin level in the 
presence of a true cobalamin deficiency will lead to clinical 
manifestations if uncorrected. Examples include an artificial increase in 
transcobalamin I and II, which can occur with myeloproliferative states, 
hepatomas, and fibrolamellar hepatic tumors; when transcobalamin II–
producing macrophages are activated in autoimmune diseases, 
monoblastic leukemias, and lymphomas; and on release of cobalamin 
from hepatocytes during active liver disease in cobalamin-deficient 
patients. Studies suggest that approximately 10% of the U.S. population, 
especially the elderly, have true cobalamin deficiency manifested by low 
or low-normal serum cobalamin levels, as well as elevated levels of 
serum methylmalonic acid (MMA) and homocysteine that fall to normal 
with cobalamin therapy 
Matchar et al did a study in 1994 to determine the use in routine 
clinical practice of the cobalamin serum assay in evaluating patients 
suspected of having cobalamin deficiency(24). The design was a 
prospective observational study of a diagnostic test compared with a 
criterion gold standard. 
Pennypacker LC, Allen RH, Kelly JP et al  in 1992 measured the 
prevalence of cobalamin (vitamin B12) deficiency in geriatric outpatients 
as documented by both low serum cobalamin levels and elevations of 
serum methylmalonic acid and homocysteine and to determine the 
response to cobalamin treatment(25). The prevalence was found to be 
very high (14.5%). 
Clarke R and Refsum et al did a screening for vitamin B12 
deficiency in older persons by measurement of serum homocysteine and 
methylmalonic acid (MMA) which were useful in borderline vitamin B12 
deficiency(26). 
Treatment 
The traditional treatment for B12 deficiency has been intramuscular 
injections. However, since as early as 1968, oral vitamin B12 has been 
shown to have an efficacy equal to that of injections in the treatment of 
pernicious anemia and other B12 deficiency states. 
Intramuscular injections, although safe and inexpensive, have 
several drawbacks. Injections are painful, medical personnel giving the 
injections are placed at risk of needlestick injuries, and administration of 
intramuscular injections often adds to the cost of therapy. Treatment 
schedules for intramuscular administration vary widely but usually 
consist of initial loading doses followed by monthly maintenance 
injections. One regimen consists of daily injections of 1,000 mcg for one 
to two weeks, then a maintenance dose of 1,000 mcg every one to three 
months. 
Although the daily requirement of vitamin B12 is approximately 2 
mcg, the initial oral replacement dosage consists of a single daily dose of 
1,000 to 2,000 mcg. This high dose is required because of the variable 
absorption of oral vitamin B12 in doses of 500 mcg or less. This regimen 
has been shown to be safe, cost-effective, and well tolerated by patients. 
Schedule for Vitamin B12 Therapy  
Oral route –initial dose of 1,000 to 2,000 mcg per day for one to 
two weeks followed by maintenance dose of 1,000 mcg per day for life. 
Intramuscular route – initial dose of 100 to 1,000 mcg every day or 
every other day for one to two weeks followed by 100 to 1,000 mcg 
every one to three months. 
Follow-Up 
After the diagnosis of vitamin B12 deficiency has been made and a 
treatment plan has been initiated, follow-up is important to determine the 
patient's response to therapy. If vitamin B12 deficiency is associated with 
severe anemia, correction of the deficiency state should lead to a marked 
reticulocytosis in one to two weeks. In mild vitamin B12 deficiency, 
repeat measurements of serum vitamin B12, homocysteine, and 
methylmalonic acid levels should be done two to three months after 
initiating treatment. 
  
 AIM AND OBJECTIVES 
1. To identify the prevalence of vitamin B12 deficiency in 100 
consecutive patients aged 65 and above attending the geriatric o.p 
at Rajiv Gandhi Government General hospital. 
2. To identify the prevalence of anemia, peripheral neuropathy and 
cognitive impairment in elderly due to Vitamin B12 Deficiency. 
MATERIALS AND METHODS 
STUDY CENTRE 
Rajiv Gandhi Government General, Hospital, Chennai – 3. 
TYPE OF STUDY 
Cross sectional study 
INCLUSION CRITERIA 
1. Patients above 65 years attending geriatric outpatient 
department    
2. Patients willing to participate in the study 
EXCLUSION CRITERIA  
1. Patients less than 65 years 
2. Patients with Diabetes Mellitus 
3. Patients with H/O chronic alcoholism 
4. Patients with hypothyroidism 
SAMPLE SIZE  
100 
METHODOLOGY  
 Serum cobalamin in our study was measured using 
Chemiluminescence Immunosorbent Assay (C.L.I.A) which is a 
commercial radioisotope dilution assay. 
 Hematologic evaluation was done by measuring hemoglobin 
and peripheral blood smear examination. 
 Neurological assessment was done by examination of deep 
tendon reflexes and sensory system. 
 Cognitive assessment was done using MMSE. 
DATA COLLECTION & METHODS  
Collection of data as per proforma with consent  from patients in 
geriatric outpatient department.          
ANALYSIS PLAN 
1. Analyzing the prevalence of anemia, peripheral neuropathy 
and cognitive impairment 
2. Analyzing the possible predisposing factors. 
3. Data analyzed using statistical package –  SPSS software 
ETHICAL CLEARANCE 
Obtained 
RESULT & ANALYSIS 
 
PREVALENCE OF VITAMIN B12 
DEFICIENCY 
 
 
100 patients (50 males and 50 females) were included in the study, 
out of which 24 of them were found to be vitamin B12 deficient.  
 
 
24%
76%
B 12 defic ient
normal
  
PREVALENCE IN MALES 
 
 
50 male patients were included in the study, out of which 11 had 
vitamin B12 deficiency with a prevalence of 22%. 
  
22%
78%
B 12 defic ient males
normal
 PREVALENCE IN FEMALES 
 
 
50 female patients were included in the study, out of which 13 had 
vitamin B12 deficiency with a prevalence of 26%. 
 
  
26%
74%
B  12 defic ient females
normal
AGE DISTRIBUTION 
 
Age group      
(in years) 
Total number 
of patients 
B12 deficient 
patients 
Prevalence 
(%) 
65-70 47 8 17 
71-75 21 6 28 
76-80 20 8 40 
>80 12 2 15 
 
 
 
DIET AND VITAMIN B12 
 
17 
28 
40 
15 
0 
5 
10 
15 
20 
25 
30 
35 
40 
45 
65-70 yrs 71-75 yrs 76-80 yrs >80 yrs 
DEFICIENCY 
Diet
Non VegetarianVegetarian
C
o
u
n
t
40
30
20
10
0
Vitamin B12
Deficiency
Normal
Excess
23
30
23
6
18
 
Vitamin B12 
deficiency 
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No 23 53 
 
 
 
 In our study, 41 patients were vegetarians and 59 patients were 
non-vegetarians. Out of 41 vegetarians, 18 had vitamin B12 deficiency 
while 23 had normal levels indicating that the prevalence of vitamin B12 
deficiency in vegetarians was 44%. 
Out of 59 non-vegetarians 6 had low vitamin B12 levels, while 30 
had normal levels and 23 of them had excess vitamin B12 levels.  
P value is less than 0.0001 and the association was extremely 
statistically significant. 
  
79% 
21% 
B12 deficient pts with 
anemia 
B12 deficient pts without 
anemia 
 
ANEMIA AND B12 DEFICIENCY 
 
 
 
 
 
 
Number of patients with B12 deficiency = 24 
Number of patients with anemia = 19 (Prevalence – 79%) 
  
B12 DEFICIENCY AND COGNITIVE 
IMPAIRMENT 
 
Number of patients with B12 deficiency = 24 
Number of patients with cognitive impairment = 4 (Prevalence – 
16%) 
  
17%
83%
B 12 defic ient pts  with
c ognitive impairment
B 12 defic ient pts  without
c ognitive impairment
8%
92%
B 12 defic ient pts  with
peripheral neuropathy
B 12 defic ient pts  without
peripheral neuropathy
B12 DEFICIENCY AND PERIPHERAL 
NEUROPATHY 
 
 
 
 
 
 
 
 
Number of patients with B12 deficiency = 24 
Number of patients with peripheral neuropathy = 2 (Prevalence – 
8%) 
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Number of patients with vitamin B12 deficiency = 24 
Number of patients with macrocytosis = 16 (prevalence 66%) 
Number of patients with microcytosis = 4 (prevalence 16%) 
Number of patients with normocytosis = 4 (prevalence 16%) 
 
 
 
 
The following diagram gives 95% confidence interval for blood 
sugar among people with vitamin B12 deficiency, normal and people with 
excessive vitamin B12. If 100 such samples are taken then 95% samples 
will have mean values as indicated by a box in the middle of vertical line 
and will have a minimum and maximum as indicated by 2 horizontal lines 
connecting the vertical line. 
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DISCUSSION 
In our study 100 patients (50 males and 50 females) were included 
out of which 24 of them were found to be B12 deficient 
Lindenbaum J and Rosenberg IH et al in 1994 determined the 
prevalence of cobalamin deficiency in Framingham elderly population. 
Out of 548 members in the study, serum cobalamin concentration < 258 
pmol/L were found in 222 subject (40.5%)(27). 
H.W. Baik and R.M. Russell in 1999 found that vitamin B12 
deficiency is estimated to affect 10%-15% of people over the age of 60, 
and the laboratory diagnosis was based on low serum vitamin B12 levels 
or elevated serum methylmalonic acid and homocysteine levels(28). 
Emmanuel Andres et al in 2004 found that vitamin B12 deficiency 
occurs frequently among elderly people and it was mainly due to food-
cobalamin malabsorption syndrome (>60%), pernicious anemia (15%-
20%), insufficient dietary intake and malabsorption(29).  
Stabler and Allen in 2004 found that  dietary vitamin B12 
deficiency is a severe problem in the Indian subcontinent, Mexico, 
Central and South America, and selected areas in Africa but is not 
prevalent in Asia, except in vegetarians(30). 
Also there are some studies done in India to determine the 
prevalence of vitamin B12 deficiency. Some of the data are as given 
below: 
INDIAN SERIES 
 
YEAR 
VITAMIN B12 
DEFICIENCY (%) 
Mittal et al 1969 22.4 
Gomber et al 1998 50.0 
Chaudhry  MW 2001 19.0 
Chandra et al 2002 32.0 
Khanduri et al 2005 33.0 
 
The above data indicate that most of the values are in the same 
range as obtained in our study (24%) 
SEX - WISE PREVALENCE 
11 out of 50 males had vitamin B12 deficiency with a prevalence of 
22% while 13 out of 50 females had vitamin B12 deficiency with a 
prevalence of 26% indicating females had more chances of developing 
B12 deficiency  
AGE – GROUP WISE PREVALENCE 
 In the study 47 patients were in the age group of 65-70 years, out 
of which 8 had vitamin B12 deficiency with a prevalence of 17% 
21 patients were in the age group of 71-75 years, out of which 6 
had vitamin B12 deficiency with a prevalence of 28% 
20 patients were in the age group of 76-80 years, out of which 8 
had vitamin B12 deficiency with a prevalence of 40% 
12 patients were in the age group above 80 years, out of which 2 
had vitamin B12 deficiency with a prevalence of 16% 
The above data indicates that prevalence of vitamin B12 deficiency 
increased steadily till the age of 80, after which it shows a gradual 
decline. 
DIET AND VITAMIN B12 DEFICIENCY 
In our study, 41 patients were vegetarians and 59 patients were 
non-vegetarians. Out of 41 vegetarians, 18 had vitamin B12 deficiency 
while 23 had normal levels indicating that the prevalence of vitamin B12 
deficiency in vegetarians was 44%. 
Out of 59 non-vegetarians 6 had low vitamin B12 levels, while 30 
had normal levels and 23 of them had excess vitamin B12 levels.  
Using the Pearson Chi-Square test, the association between 
vegetarian diet and vitamin B12 deficiency was found to be extremely 
stastically significant. (p value <  0.0001).  
RELATIONSHIP BETWEEN VITAMIN B12 DEFICIENCY AND 
BLOOD SUGAR, BLOOD UREA, SERUM CREATININE AND 
SERUM PROTEIN 
 If mean values of more than two groups are to be compared, then 
One way Analysis Of Variance (ANOVA) has to be applied. In the 
present study, it is of interest to know whether vitamin B12 deficiency has 
got any effect on blood sugar. blood urea, serum creatinine and serum 
protein of patients. These levels are compared with 3 groups of people 
namely, vitamin B12 deficient people, normal people and people having 
excess of vitamin B12. 
Null hypothesis that is being tested is that mean levels of three 
groups compared with reference to each one of the four levels are the 
same. Null hypothesis has to be rejected if significance value of ANOVA  
is less than 0.05. Otherwise there is no reason to reject the null 
hypothesis. In the present study significant value of all the four levels are 
greater than 0.05 and hence we conclude that neither blood sugar, blood 
urea, serum creatinine or serum protein has any effect over vitamin B12 
deficiency. 
Student t test is used to compare the mean values of two groups at 
a time. The null hypothesis assumed in t test is that mean value of two 
groups compared are the same against the alternative that mean values are 
not the same. 
VITAMIN B12 DEFICIENCY AND ANEMIA 
Out of the 24 patients with vitamin B12 deficiency, 19 had anemia 
with a prevalence of 79%. Also 32 out of 53 people with normal B12 
levels had anemia with a prevalence of 60% while 11 out of 23 people 
with vitamin B12 excess had anemia with a prevalence of 47%. 
VITAMIN B12 DEFICIENCY AND PERIPHERAL BLOOD SMEAR 
Out of the 24 patients with vitamin B12 deficiency, 16 presented 
with macrocytosis with a prevalence of 66% while 4 persons presented 
with microcytosis with a prevalence of 16% whereas remaining 4 persons 
were normocytic.   
VITAMIN B12 DEFICIENCY AND PERIPHERAL NEUROPATHY 
Out of 24 patients with vitamin B12 deficiency, 7 had complaints of 
numbness and paraesthesis, while 17 did not. 11 out of 53 patients with 
normal B12 levels had similar complaints while out of 23 patients with 
excess B12 levels 8 had the complaints. 
Out of 24 patients with vitamin B12 deficiency, 2 had peripheral 
neuropathy with a prevalence of 8%. Also 4 out of 53 people with normal 
B12 levels had peripheral neuropathy with a prevalence of 7% while it 
was found in 5 out of 23 people with excess B12 levels with a prevalence 
of 21%. 
VITAMIN B12 DEFICIENCY AND COGNITIVE IMPAIRMENT 
Out of 24 patients with vitamin B12 deficiency, 4 had cognitive 
impairment with a prevalence of 16%. Also 7 out of 53 people with 
normal B12 levels had cognitive impairment with a prevalence of 13% 
whole was found in 5 out of 23 people with excess B12 levels with a 
prevalence of 21%. 
In clinical practice, it is found that patients with cognitive 
impairment associated with vitamin B12 deficiency often improve on 
treatment, whereas those with obvious dementia usually show no 
improvement. However, these are essentially anecdotal reports and there 
have been very few randomized controlled trials in which vitamin B12 
alone has been given to elderly people with cognitive impairment or 
dementia. The Cochrane review in 2003 could find only 2 trials with 
acceptable methodology, which had a total of 42 patients enrolled, of 
whom only 36 completed the trials. Treatment periods were 1 or 5 mo. 
The endpoints were changes in the Mini-Mental State Examination or 
Alzheimer's Disease Assessment Scale–Cognitive, which assess global 
cognitive abilities: no difference was found between treated and placebo 
groups. A recent systematic review identified 6 trials that satisfied their 
methodologic criteria, but the wide variety of doses used and the 35 
different cognitive function tests made it difficult to come to any 
conclusion. Notably, some of the trials reported a worsening of cognition 
in the vitamin B12 treated groups compared with those receiving placebo. 
But in 4 of the 6 trials, the participants were normal elderly without 
cognitive impairment. It is clear that no conclusions can be drawn from 
the published trials. The trials have all been underpowered, too short in 
duration, and often carried out on the wrong type of subject. It can be 
concluded that ―Large randomized trials are required to evaluate the value 
of vitamin B12 for improving cognitive function and preventing or 
retarding cognitive decline in normal and demented older people. Trials 
need to use established and validated diagnostic criteria and measures of 
cognitive function and to be long enough to detect trends‖. 
Given the complexity of the mechanisms related to cognitive 
changes in the elderly, and the metabolic relationship between B vitamins 
and homocysteine levels, the association between B-vitamin status and 
subsequent cognitive function remains unclear. This systematic review of 
observational studies investigates the association between blood levels or 
dietary intake of B vitamins and the risk and progression of 
neurocognitive deficit as measured by cognitive tests and age-related 
neurodegenerative disorders such as Alzheimer's disease in humans. 
  
 CONCLUSION 
1. Out of the 100 consecutive patients studied 24 of them were found 
to be Vitamin B12 deficient. 
2. A strong association between B12 deficiency and anemia was noted 
but not with peripheral neuropathy and cognitive impairment. 
3. Association between vegetarian diet and B12 deficiency was found 
to be extremely statistically significant. (P value < 0.0001) 
4. Prevalence of Vitamin B12 deficiency increased steadily till the age 
of 80 after which it showed a gradual decline. 
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ABBREVIATIONS 
 
 
MMSE  – Mini-Mental Status Examination 
 
MMA  - MethylMalonic Acid 
 
Cbl   - Cobalamin 
 
H2 blockers  – Histamine-2 blockers 
 
PPIs    –  Proton pump inhibitors 
 
IF    - Intrinsic Factor 
 
TC I    - Transcobalamin I 
 
TC II    – Transcobalamin II 
 
HCs    - Haptocorins 
 
SAM    - S – adenosyl methionine  
 
THF   - Tetra Hydro Folate  
 
 
PROFORMA 
 
NAME: 
 
AGE: 
 
SEX: 
 
OP NO: 
 
ADDRESS: 
 
PAST HISTORY: 
1. Diabetes Mellitus  
2. Hypothyroidism 
3. Alcoholism 
4. Drug intake 
 
H/O EASY FATIGUABILITY: 
 
H/O NUMBNESS AND PARATHESIA: 
 
H/O MEMORY DISTURBANCES: 
 
MMSE SCORE :  / 30 
 
SENSORY SYSTEM EXAMINATION 
 TOUCH 
 TEMPERATURE 
 PAIN 
 VIBRATION 
 JOINT POSITION 
INVESTIGATIONS 
1. HEMOGLOBIN 
2. RENAL FUNCTION TEST 
                         Sugar 
           Urea 
           Creatinine 
3. PERIPHERAL BLOOD SMEAR 
4. THYROID FUNCTION TEST 
5. VITAMIN B12 LEVEL 
 
TICK WHICHEVER IS APPLICABLE 
ANEMIA   
 
PERIPHERAL NEUROPATHY 
 
DEMENTIA    
 
 
“Mini-Mental” status test of Folstein, Folstein, and McHugh 
 
TASK  INSTRUCTIONS   SCORING 
Date orientation    ―Tell me the date?‖           One point each for year,  5 
                              Ask for omitted items.          season, date, day of 
                                                                            week, and month 
 
Place orientation   ―Where are you?‖ Ask     One point each for state,  5 
                              for omitted items.                  county, town, building, 
                                                                             and floor or room 
Register three      Name three objects slowly One point for each item  3 
                              and objects clearly. Ask         correctly repeated 
                              the patient to repeat them. 
 
Serial sevens       Ask the patient to count       One point for each  5 
                              backwards from 100 by 7.    correct answer (or letter) 
                              Stop after five answers.  
                              (Or ask them to spell 
                              ―world‖ backwards.)  
 
Recall three          Ask the patient to recall     One point for each item     3 
objects                  the objects mentioned           correctly remembered 
                             above. 
 
Naming             Point to your watch and         One point for each            2 
                             ask the patient ―what is          correct answer 
                             this?‖ Repeat with a pencil. 
 
Repeating a        Ask the patient to say            One point if successful     1 
phrase                   ―no ifs, ands, or buts.‖           on first try 
 
Verbal                Give the patient a plain         One point for each            3 
commands            piece of paper and say           correct action 
                             ―Take this paper in your  
                             right hand, fold it in half,  
                             and put it on the floor.‖ 
 
 
Written                Show the patient a piece        One point if the                1 
commands           of paper with ―CLOSE           patient‘s eyes close 
                            YOUR EYES‖ printed on it. 
 
Writing                Ask the patient to write         One point if sentence       1 
                             a sentence.                             has a subject, a verb,  
                                                                           and makes sense 
 
Drawing            Ask the patient to copy           One point if the               1 
                          a pair of intersecting               figure has ten corners 
                          pentagons onto a piece           and two intersecting lines 
                          of paper. 
 
Scoring            A score of 24 or above is considered normal.            30 
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